desipramine has been researched along with Pain, Intractable in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Pain, Intractable: Persistent pain that is refractory to some or all forms of treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansuategui Sánchez, M | 1 |
| Rodríguez Hernández, JL | 1 |
| López Manzanero, L | 1 |
| González Miranda, F | 1 |
1 other study available for desipramine and Pain, Intractable
| Article | Year |
|---|---|
[Analgesia with desipramide in neoplastic chronic pains].
Topics: Adult; Aged; Desipramine; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Pain, Intra | 1980 |